Early diagnosis is critical for managing SCID effectively. The diagnosis is typically made through newborn screening programs, which include a test called the T cell receptor excision circle (TREC) assay. This test measures the number of T cells in the blood. If the TREC assay indicates low or absent T cells, further genetic testing is performed to confirm the diagnosis.
